Copyright
©The Author(s) 2021.
World J Gastroenterol. Mar 7, 2021; 27(9): 782-793
Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.782
Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.782
Figure 1 Comparison of clinical outcomes of coronavirus disease 2019 in hepatitis B virus and non-hepatitis B virus groups.
A: Discharge rate; B: Mortality rate; C: Proportion of severe/critically ill patients. The data were collected from different clinical studies. COVID-19: Coronavirus disease 2019; HBV: Hepatitis B virus.
Figure 2 Graphical abstract.
COVID-19: Coronavirus disease 2019; HBV: Hepatitis B virus; IFN: Interferon; IL: Interleukin; RdRp: RNA-dependent RNA polymerase; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; TNF-α: Tumor necrosis factor-alpha.
- Citation: Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World J Gastroenterol 2021; 27(9): 782-793
- URL: https://www.wjgnet.com/1007-9327/full/v27/i9/782.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i9.782